Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amer Zeidan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The New Zealand Medical Journal|August 19, 2008
Medical image. Mediastinal mass in a patient with coronary artery diseaseAmer Zeidan
Cancer Genetics and Cytogenetics|February 26, 2008
Acquired biclonal chromosome X aberrations without autosomal chromosomal anomalies in acute myeloid leukemiaAmer Zeidan, Pradyumna Phatak
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Trends in Clinical Investigation for Myelodysplastic SyndromesThomas Prebet, Amer Zeidan
World Journal of Stem Cells|November 27, 2014
Stem cells in gastrointestinal cancers: The road less travelledSameh Mikhail, Amer Zeidan
Expert Review of Hematology|October 8, 2013
Myelodysplastic syndromes: toward a risk-adapted treatment approachBishoy Faltas, Amer Zeidan, Usama Gergis
Journal of Hospital Medicine|December 1, 2011
Dabigatran etexilate: what do hospitalists need to know?Amer Zeidan, Bishoy Faltas, Michael Streiff
Expert Review of Anticancer Therapy|September 10, 2014
Hepatocellular carcinoma: systemic therapies and future perspectivesSameh Mikhail, David Cosgrove, Amer Zeidan
Expert Opinion on Biological Therapy|December 10, 2008
Pegasparaginase: where do we stand?Amer Zeidan, Eunice S Wang, Meir Wetzler
Clinical Advances in Hematology & Oncology : H&O|October 2, 2008
What is imatinib-resistant chronic myeloid leukemia? Identifying and managing loss of responseAmer Zeidan, Eunice S Wang, Meir Wetzler
Expert Review of Hematology|February 14, 2014
An update on type 2B von Willebrand diseaseSameh Mikhail, Ehab Saad Aldin, Michael Streiff, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|August 19, 2008
Medical image. Mediastinal mass in a patient with coronary artery diseaseAmer Zeidan
Cancer Genetics and Cytogenetics|February 26, 2008
Acquired biclonal chromosome X aberrations without autosomal chromosomal anomalies in acute myeloid leukemiaAmer Zeidan, Pradyumna Phatak
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Trends in Clinical Investigation for Myelodysplastic SyndromesThomas Prebet, Amer Zeidan
World Journal of Stem Cells|November 27, 2014
Stem cells in gastrointestinal cancers: The road less travelledSameh Mikhail, Amer Zeidan
Expert Review of Hematology|October 8, 2013
Myelodysplastic syndromes: toward a risk-adapted treatment approachBishoy Faltas, Amer Zeidan, Usama Gergis
Journal of Hospital Medicine|December 1, 2011
Dabigatran etexilate: what do hospitalists need to know?Amer Zeidan, Bishoy Faltas, Michael Streiff
Expert Review of Anticancer Therapy|September 10, 2014
Hepatocellular carcinoma: systemic therapies and future perspectivesSameh Mikhail, David Cosgrove, Amer Zeidan
Expert Opinion on Biological Therapy|December 10, 2008
Pegasparaginase: where do we stand?Amer Zeidan, Eunice S Wang, Meir Wetzler
Clinical Advances in Hematology & Oncology : H&O|October 2, 2008
What is imatinib-resistant chronic myeloid leukemia? Identifying and managing loss of responseAmer Zeidan, Eunice S Wang, Meir Wetzler
Expert Review of Hematology|February 14, 2014
An update on type 2B von Willebrand diseaseSameh Mikhail, Ehab Saad Aldin, Michael Streiff, et al.
Pageof 4